↓ Skip to main content

Dove Medical Press

Review of mifamurtide in the treatment of patients with osteosarcoma

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
100 Mendeley
Title
Review of mifamurtide in the treatment of patients with osteosarcoma
Published in
Therapeutics and Clinical Risk Management, June 2010
DOI 10.2147/tcrm.s5688
Pubmed ID
Authors

Leo Kager, Ulrike Pötschger, Stefan Bielack

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 99 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 21%
Researcher 15 15%
Student > Master 12 12%
Student > Bachelor 9 9%
Other 7 7%
Other 19 19%
Unknown 17 17%
Readers by discipline Count As %
Medicine and Dentistry 30 30%
Biochemistry, Genetics and Molecular Biology 12 12%
Pharmacology, Toxicology and Pharmaceutical Science 11 11%
Agricultural and Biological Sciences 9 9%
Chemistry 4 4%
Other 11 11%
Unknown 23 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2024.
All research outputs
#5,053,885
of 26,225,548 outputs
Outputs from Therapeutics and Clinical Risk Management
#235
of 1,335 outputs
Outputs of similar age
#20,399
of 109,044 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 5 outputs
Altmetric has tracked 26,225,548 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,335 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,044 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.